Biological Role of PER2 & Gene Editing Prospects

Abstract

The PER2 gene plays an extremely important role in the body's internal clock by helping

regulate daily rhythms like sleep and consciousness. It is an extremely important part of the

feedback loop that drives the circadian cycle, especially in areas like the suprachiasmatic nucleus

(SCN), which controls our biological clock's timing. This review looks into whether the current

gene editing technologies like CRISPR-Cas9 could be used to address problems that exist with

PER2 expression. We assess how PER2 dysfunction is linked to circadian rhythm disorders such

as Delayed Sleep Phase Syndrome (DSPS) and review the findings from case studies and

research that cover both humans and animals. Additionally, the paper discusses the technical and

biological challenges of editing a gene that changes over a 24-hour cycle and is only active in

certain brain regions. We also look at the ethical and safety concerns that are associated with

targeting genes in the brain, especially ones correlated to behavior and sleep. This understanding

of the PER2 gene's influence helps us explore the potential of safe and targeted gene therapy

guidelines implemented in the near future, especially with such a steadily growing market.

Introduction

Our bodies run on an internal clock called the circadian rhythm, which repeats roughly every 24

hours. This clock helps regulate a wide range of functions like sleep, body temperature,

digestion, and hormone release. It keeps us aligned with the day-night cycle and plays a big role

in keeping us healthy and alert. When the circadian rhythm is off, even slightly, it can lead to

sleep problems and other health issues.

One of the key genes involved in keeping this rhythm stable is PER2. It's essentially part of a

group informally named “clock genes” that turn on and off in a regular cycle to keep a record of

time inside our cells. PER2 is especially active in a part of the brain called the suprachiasmatic

nucleus (SCN), which is basically the body's master clock. When PER2 isn't working correctly,

whether due to a genetic mutation or changes in its gene expression, it can throw off the timing

of the rest of the circadian rhythm. This malfunctioning can lead to disorders like Delayed Sleep

Phase Syndrome (DSPS), where people naturally fall asleep and wake up much later than usual,

shifting their sleep cycle forward.

With new advances in gene editing tools like CRISPR, scientists are beginning to explore the

possibility of using these technologies to completely fix or perform minor adjustments on genes

like PER2. The idea, in essence, is that by editing the gene, there is a possibility of being able to

“reset” a person's internal clock at the source and treat their sleep disorder more effectively than

with traditional medications or therapies. Whether it is through single-point mutations or

correcting over- or underexpression, gene editing must be precise using safe delivery methods to

maintain its target and disrupt the circadian feedback loop. However, editing a gene that controls

such a complex and time-sensitive system isn't simple. There are major challenges, like making

sure the editing happens at the right moment, in the right location of the body, and ensuring it

does not result in any unwanted side effects.

In this paper, we will take a closer look at how PER2 works, how its disruption can affect the

sleep process, and whether gene editing has the potential to become a useful way to treat any

existing circadian rhythm disorders. We will also cover some of the biggest challenges and

ethical concerns that are present when it comes to editing genes that control how our bodies

function daily.

Biological Role of PER2

The PER2 protein also acts as a central regulator of the transcription-translation feedback loop

(TTFL) that contributes to setting the mammalian circadian clock. CLOCK–BMAL1

heterodimers, which are a family of protein transcription factors, bind to E-box elements to

activate transcription of the PER and CRY genes (such as PER2) and start the circadian feedback

loop. The PER2 protein translated from this then binds to CRY proteins (initiated in turn by

CLOCK–BMAL1) that are exported into the nucleus and repress CLOCK–BMAL1, closing the

negative feedback loop required to maintain ~24‐hour cycles in the suprachiasmatic nucleus

(SCN) and peripheral tissues (Etchegaray et al. 2009). This transcriptional feedback is controlled

at a number of levels of regulation for precision and circadian rhythm consistency day to day.

Figure 1. Circadian Rhythms are controlled by a phosphorylation-regulated negative feedback

loop. Early in the circadian cycle, PER, CKI, and CRY proteins multimerize in the cytoplasm and

then translocate to the nucleus to repress the CLK:BMAL1 transcription factor. Potential

functional effects of CKIδ and CKIε (denoted CKIε for simplicity) include (1) degradation of

PER early in the accumulation phase, delaying repression; (2) regulating PER nuclear entry of

the inhibitor complex, or (3) promoting degradation of PER, thereby terminating repression. The

stabilizing Rev-Erbα loop is not shown here. (Virshup et al., 2007)

One of the significant regulatory layers is at the translational level by means of a conserved

upstream open reading frame (uORF) in the 5' UTR region of the Per2 gene. In conditions of

homeostasis, this uORF suppresses the translation of PER2. Physiologically significant

temperature rise (e.g. 35 - 38 °C), however, operates to relieve such suppression and augment

PER2 protein synthesis without altering the amount of mRNA and thereby training such cell

cycles to comply with their optimal temperature environment (Miyake et al. 2023). This action

adds a non-photic activation pathway, allowing organisms to synchronize with daily thermal

fluctuation stimulation independently of transcriptional change at the gene itself.

Further regulation is achieved post-translationally through phosphorylation by casein kinase 1δ/ε

(CK1δ/ε). PER2 undergoes hierarchical multisite phosphorylation, a process in which phosphate

groups are deposited sequentially onto multiple sites on the protein. Phosphorylation generates a

phosphoswitch that regulates PER2 stability. The equilibrium between a stabilizing FASP

domain and a phospho-degron mediating PER2 degradation is kept in the switch. The

degradation of PER2 is therefore well-regulated and plays a role in circadian periodicity

regulation (Narasimamurthy and Virshup 2018; Hildebrand et al. 2021). Stabilization and

reduced degradation of PER2 are mediated by phosphorylation at the FASP site, whereas

phosphorylation of the degron increases ubiquitination and proteasomal elimination via β-TrCP

(Masuda et al. 2020). Disrupting this balance, either by mutation of the stabilizing or degron

regions, generates altered circadian lengths and impaired temperature compensation, disrupting

the stability of the organism's circadian rhythms (Masuda et al. 2020; Vanselow et al. 2024).

Phosphoswitch model. PER2 regulates the speed of the circadian clock through the axis

CDK5-CKI. When PER2 is phosphorylated by CDK5, it is stabilized and goes into the nucleus.

Under normal conditions, nuclear PER2 is phosphorylated by CKI ε/δ at Ser-477 which is

followed by nucleus/cytoplasm shuttling and proteasomal degradation. However, following a

switch in the temperature, PER2 can be phosphorylated at the FASP sites

(pS659-662-665-668-671), which stabilizes the protein. As a consequence, the clock is slowed

down. Additionally, CDK5 and CKI can reciprocally regulate their activity, speeding up or

slowing down the clock accordingly. (Brenna & Albrecht, 2020, Fig 4)

Genetic disruption of PER2 regulation confirms its function in circadian rhythm regulation. The

FASP domain S662G mutation reduces CK1 priming phosphorylation, destabilizes PER2,

increases degradation, and induces familial advanced sleep phase syndrome (FASPS)

(Narasimamurthy and Virshup 2018; Hildebrand et al. 2021). Disruption of the degron site,

however (S478A in mouse), increases PER2 half-life and extends the circadian period and

demonstrating that both increased and slowed PER2 turnover disrupts timing accuracy (Masuda

et al. 2020; Vanselow et al. 2024). uORF ablation also alters thermal entrainment dynamics

(Miyake et al. 2023), further supporting the conclusion that temporal control of PER2 translation

and degradation is required to maintain circadian integrity.

The role of PER2 is found to become increasingly tissue-specific, with varying effects based on

the organ system in question. PER2, in the liver, is implicated in the modulation of metabolic

rhythms, and liver-specific deletion of Per2 induces irregularities in lipid metabolism and

glucose homeostasis while maintaining the central SCN rhythm intact (Zhang et al. 2017). In

skeletal muscle, PER2 coordinates with local metabolic cues to modulate mitochondrial

oxidative potential and insulin sensitivity, suggesting its role beyond temporal regulation (Dyar

et al. 2014). Concurrently, within immune cells, PER2 controls cytokine expression and

inflammation, which indicates its association with immunometabolism and circadian fluctuation

in immune function (Nguyen et al. 2013).

PER2 disruption has also been implicated in various states of disease. Within cancer, PER2

functions as a tumor suppressor by regulating cell cycle checkpoints and apoptosis. Its

downregulation is also seen in breast and colorectal cancer, where it plays a role in enhanced

proliferation and adverse prognosis (Fu et al. 2022). In metabolic disorders, disrupted PER2

expression is associated with obesity and type 2 diabetes, as desynchronized feeding patterns and

disrupted circadian rhythms affect insulin signaling and energy storage (Zhang et al. 2016).

PER2 has also been implicated in mood and neuropsychiatric disorders. Animal models show

that reduced PER2 expression correlates with depression-like behavior and impaired reward

sensitivity, at least via dopaminergic circuit deregulation (Hampp et al. 2008).

Finally, other environmental stimuli apart from light and temperature influence PER2 dynamics.

Peripheral PER2 rhythms are modulated by circadian time under an unchanged light-dark cycle,

showing nutrient timing to be a potent zeitgeber for organs like the liver and gut (Hirao et al.

2010). Oxidative stress also activates PER2 due to ROS accumulation, suggesting that the

cellular redox state signals to the circadian system through stress-responsive transcription factors

(Jacobi et al. 2015). These findings highlight PER2's greater role as an integrative node,

coordinating environmental and physiological inputs to generate appropriate circadian

regulation.

Taken together, these open-access articles explain how PER2 employs transcriptional,

translational, and post-translational cues to function as a temperature-compensated molecular

timer. The synergy between uORF-directed translation, CK1-dependent phosphorylation, and

feedback repression by PER2/CRY complexes enables stable ~24‐hour oscillation in SCN

neurons and peripheral clocks. Perturbation of any of these regulatory layers, via mutation,

environmental stress, or genetic manipulation, leads to aberrant circadian timing, testifying to the

multi-tiered nature of PER2's role in chronobiology.

Circadian Rhythm Disorders

Circadian rhythm disorders are conditions where the internal body circadian clock is not

synchronized with the outside world, leading to persistent sleep time and quality problems.

Delayed Sleep Phase Syndrome (DSPS) is a condition in which there is a persistent delay in

sleep and wake times with respect to societal norms, leading to chronic insomnia and impairment

of daytime functioning (Wheaton et al. 2016). DSPS is generally hereditary, and this means there

is a genetic basis for the disturbed circadian timing. Dysregulation of the major clock genes,

including PER2, is increasingly implicated in DSPS and other sleep disorders. PER2 plays an

essential role in the perpetuation of the 24-hour rhythm by modulating feedback inhibition of the

circadian TTFL (Patke et al. 2017).

PER2 gene mutations were directly implicated in DSPS and other sleep disorders. One of the

best-studied mutations is the S662G substitution in the human PER2 protein, which disrupts the

CK1δ/ε phosphorylation site necessary for proper PER2 stability and degradation (Toh et al.

2001). The mutation leads to premature PER2 degradation, shortening the period of feedback

inhibition and causing a phase advance in the circadian rhythm, leading to familial advanced

sleep phase syndrome (FASPS). Conversely, PER2 dysregulation can also cause DSPS, while

increased PER2 turnover lengthens the circadian period and advances sleep (Patke et al. 2017).

Animal model research shows that mice deficient in Per2 exhibit disrupted activity rhythms and

disordered sleep structure, indicating that PER2 is essential for circadian period and sleep

structure maintenance (Zheng et al. 1999).

Total evidence from animal models and human studies highlights the functional significance of

PER2 dysregulation. Knock-in mice that carry the human S662G PER2 mutation show a shorter

circadian period and earlier activity onset, which is recapitulation of FASPS phenotypes in

humans (Xu et al. 2005). Per2 null mice, however, display longer circadian periods and sleep

cycle disorder (Zheng et al. 1999). Furthermore, recent transcriptomic studies in human DSPS

patients reveal dysregulated clock gene and PER2 expression profiles in peripheral blood

mononuclear cells, confirming the molecular pathogenesis of the condition (Kovanen et al.

2021). Molecular changes are then linked with enhanced melatonin and core body temperature

rhythm delay of secretion characterized clinically in DSPS patients (Smith et al. 2018).

Interestingly, PER2 dysfunction is not an independent phenomenon but operates in conjunction

with other clock components and environmental cues. The CK1δ/ε-dependent phosphoswitch

that regulates PER2 stability is subject to genetic mutation as well as environmental entraining

cues such as light and temperature, modifying the severity of circadian dysrhythmia (Lee et al.

2011). Recent work also suggests that PER2 further impinges on downstream targets of

metabolism and neurobehavior, further implicating circadian dysfunction with systemic

consequences. For example, PER2 controls dopaminergic activity in the striatum, so PER2

deletion interferes with reward-seeking behavior as well as with sleep-wake stability (Choi et al.

2021). In addition, pharmacological efforts to stabilize PER2 by CK1δ/ε inhibition or PER2

transcriptional activation with small molecules have been reported to reverse normal rhythms in

mouse models (Hirano et al. 2016).

Light therapy has also emerged as a non-invasive treatment to modulate PER2 expression in

DSPS patients. Early morning time-of-day bright light exposure has been shown to

phase-advance circadian rhythms by increasing PER2 mRNA levels in peripheral tissues (Skene

and Arendt 2007). The efficacy of light treatments is an indicator of the activity of PER2 as a

light-responsive gene under CLOCK:BMAL1 transcriptional regulation and subsequent

integration into behavior rhythms. In addition, nutritional and metabolic cues—i.e., restricted

feeding regimens—have also been found to entrain peripheral clocks independently of the SCN

using PER2-dependent pathways (Zhang et al. 2009). This corroborates PER2's role in central

and peripheral circadian systems, validating its function in DSPS pathophysiology.

Gene control tools, including CRISPRa, are also being investigated to overexpress PER2 in

circadian misalignment models. Preliminary evidence suggests that quite modest overexpression

of PER2 transcription is sufficient to reconstitute rhythmicity in PER2-deficient cell lines

without disrupting other clock genes (Takahashi et al. 2015). Molecular treatments, combined

with behavioral and pharmacological strategies, present an exciting multimodal platform for

treating DSPS in genetically vulnerable subjects.

Gene Editing Technologies

Gene editing technologies have transformed the world of molecular biology by enabling the

manipulation of genomic sequences with unprecedented accuracy. Among them, the

CRISPR-Cas9 system has been the most favored due to its ease of use, efficiency, and

programmability. Originally described as a bacterial adaptive immune system, CRISPR-Cas9

uses a guide RNA (gRNA) to direct the Cas9 endonuclease to a particular DNA sequence,

introducing double-strand breaks (DSBs) at the target locus. Host repair of the DSBs via

non-homologous end joining (NHEJ) or homology-directed repair (HDR) pathways can be

hijacked to generate targeted gene knockouts, insertions, or exact sequence edits (Jinek et al.

816; Doudna and Charpentier). Apart from canonical CRISPR-Cas9, newer tools such as

CRISPR activation (CRISPRa) and interference (CRISPRi) enable gene expression to be

regulated, regardless of DNA sequence alteration, by utilizing catalytically dead Cas9 (dCas9)

fused to transcriptional activators or repressors, respectively (Qi et al. 1173). Base editors expand

this toolkit by allowing direct change of single nucleotides (e.g., C-to-T or A-to-G) without the

induction of DSBs, reducing off-target effects and increasing precision in genetic correction

(Komor et al. 420). Collectively, these technologies offer multifaceted solutions to the control of

gene function at multiple levels of gene regulation.

Gene editing tools for the PER2 gene are of tremendous potential in cutting its function in

circadian biology and even in treating circadian rhythm disorders. CRISPR-Cas9 can be used to

generate PER2 knockouts to study loss-of-function phenotypes or repair disease-causing

mutations such as those involved in familial advanced sleep phase syndrome (FASPS) (Xu et al.

640). HDR-mediated editing of point mutations in the PER2 gene can restore normal protein

function in patient cells. In addition, CRISPRa approaches can rhythmically or tissue-specifically

enhance PER2 expression, with the potential to rescue disrupted oscillations in certain sleep

disorders. Conversely, CRISPRi can transiently suppress ectopic PER2 expression, offering a

reversible approach to modulate the clock without permanently editing the DNA. Base editing,

as it is precise, would have the capacity to selectively edit phosphorylation sites within PER2

that regulate its stability and nuclear localization, with high specificity precision tuning circadian

period length and phase (Lee et al. 1013).

Of critical importance in the application of gene editing to PER2 is the timing and tissue

specificity of interventions, reflecting the gene's endogenous circadian regulation and principal

function within the suprachiasmatic nucleus (SCN). The circadian system is highly responsive to

temporal cues, with PER2 expression strongly oscillating in SCN neurons and peripheral tissues

in a rigorously controlled 24-hour cycle (Takumi et al.). Constitutive editing or regulation of

PER2 in all tissues and at all times, then, holds the potential to disrupt physiological rhythms,

exerting deleterious effects such as sleep disorders or metabolic dysregulation. Inducible

CRISPR systems that can be activated or repressed by external stimuli, such as doxycycline,

rapamycin, or light, have also been useful tools for temporally specific intervention (Zetsche et

al. 139). These allow scientists to apply genetic modifications only during particular circadian

phases, reducing the risk of chronobiological disruption.

Tissue-specific delivery systems are also important. Adeno-associated viruses (AAVs) with

neuronal tropism are especially well-suited to target the SCN and other neuronal regions of the

brain that control circadian rhythms (Khan et al. 164). New synthetic vectors and lipid

nanoparticles also enable gene delivery with reduced immunogenicity and increased penetration

of the blood-brain barrier. Recent research has also drawn attention to the potential of

CRISPR-Cas systems paired with optogenetic modules, which allow editing to be regulated

spatially and temporally through exposure to light, a tool especially suitable to the light

responsiveness of the circadian system (Abudayyeh and Gootenberg 271). Such developments

are designed to maximize efficacy and minimize systemic side effects.

Therapeutic ramifications beyond basic research, meanwhile, are vast for gene editing

technologies being brought to bear on PER2. Circadian rhythm disorders like delayed sleep

phase syndrome and non-24-hour sleep-wake disorder result from mutations or misregulation of

clock genes like PER2. Personalized gene therapies would restore normal oscillatory function,

resulting in improved sleep quality and overall health (Sancar et al. 1636). Furthermore, the

circadian clock also controls a broad range of physiological processes, including metabolism,

immune response, and drug response, and thus the accurate regulation of PER2 expression is

likely to find broad clinical application beyond sleep (Bass and Takahashi 1349). Impaired PER2

function has also been implicated in certain cancers, where disruption of circadian function can

contribute to tumorigenesis, further broadening the potential of PER2 as a gene therapy target

(Fu et al. 213). However, challenges remain in delivering long-term safety, minimizing immune

responses, and achieving durable alterations in expression. Rigorous preclinical development

using animal models of circadian disruption is needed to confirm gene editing approaches for

clinical translation.

In summary, modern gene editing tools such as CRISPR-Cas9, CRISPRa/i, and base editors offer

powerful and versatile approaches to regulating PER2 gene function with high precision. They

hold the promise to both advance our understanding of circadian biology and develop novel

therapies for circadian rhythm disorders. Perhaps most critically, the effectiveness of these

strategies will demand consideration of the temporal and spatial dynamics of PER2 expression,

calling for advances in inducible and tissue-specific editing strategies to preserve physiological

rhythms while correcting dysfunction.

Mechanism of the CRISPR/Cas9 gene editing system. The single guide RNA (sgRNA) directs the

Cas9 nuclease to a complementary sequence in the genome where Cas9 will induce a

double-strand break (DSB). The target genomic locus must be followed by a 5′-NGG-3′motif

(protospacer adjacent motif, PAM) for Cas9 to function. DSBs are repaired by non-homologous

end joining (NHEJ) or by homology-directed repair (HDR) in the presence of a DNA repair

template, which can be exploited to introduce precise genetic modifications or exogenous

sequences. (Zhang et al., 2021)

Proposed model of the effects of PER2 silencing on lipid synthesis and cell cycle activity in

primary bovine mammary epithelial cells based on results from the present study. (Jing et al.,

2021)

Challenges in Targeting PER2 with Gene Editing

The circadian system creates many important physiological rhythms through the use of a tightly

regulated transcription-translation feedback loop (TTFL). PER2 is one of its most important

components and performs an important role in sustaining approximately 24-hour cycles. On the

other hand, having to manipulate PER2 for therapeutic or investigative purposes also comes with

challenges, especially when maintaining temporal precision, making sure of tissue-specific

relevance, and avoiding any systemic disruption. Qian et al. (2023) addresses these concerns by

implementing an innovative multi-tissue proteomics approach in the Per1/Per2 double knockout

mice to offer more insight into the gene's regulatory reach.

Beyond the proteomic rhythms, multiple additional studies have shown that PER2 also acts as an

important metabolic and transcriptional regulator across various types of systems. For example,

Grimaldi et al. (2011) identified PER2 as a direct repressor of PPARγ which is a central

transcription factor that is involved in lipid metabolism and adipocyte differentiation. This

suggests the possibility that PER2 disruption may result in broad metabolic effects that are

off-target and will further complicate any efforts to study or modulate its function. Similarly,

Hoshi et al. (2017) studied the PER2-dependent angiogenic rhythms in skin tissue and focused

on the importance of local tissue environments in the circadian outcomes.

A proteomic study that was conducted by Qian et al. (2023) used quantification based on tandem

mass tag (TMT) of protein rhythms across eight different tissues in Per1/Per2 double knockout

mice. Tissues were sampled at intervals of 2 hours under darkness to eliminate any entrainment

caused by light and to help with the analysis of endogenous circadian rhythmicity. This method

allowed the researchers to identify thousands of oscillating proteins in types of wild animals and

compare them to arrhythmic/altered patterns that were present in mutant mice.

Temporal Precision

In the study by Qian et al. (2023), researchers found a major loss of rhythmic protein activity in

nearly every tissue of mice that had both Per1 and Per2 genes knocked out of them. Generally, in

wild types of mice, a large number of proteins will display regular approximately 24-hour cycles

in their activity levels. But in the knockout mice, this rhythm was almost completely gone -

especially in proteins related to metabolism and cell signaling. This shows that PER2 is

important to keep the internal timing system of the body working properly. When PER2 is not

working, it's not just the timing or strength of these cycles that are affected, but the basic

structure of the circadian clock itself falls apart. This is likely because PER2 helps control the

CLOCK:BMAL1 complex and keeps the rest of the circadian system stable. Building on this,

Hoshi et al. (2017) looked at how PER2 affects specific tissues, such as the skin. They showed

that in PER2-deficient mice, important genes involved in blood vessel growth (like ANGPTL1)

lost their normal rhythm. This caused issues with how quickly wounds healed and how well

blood vessels repaired themselves. So PER2 isn't just involved in setting the body's overall

internal clock. It also plays an important role in managing time-sensitive processes right where

they happen, like in the skin.

Tissue Specificity

Qian et al. also showed that PER2's role is different depending on the tissue. In the wild-type

mice, organs like the liver, heart, and brown fat had strong and regular cycles in their protein

activity. But when PER2 was knocked out, these rhythms didn't disappear in the same way in

every tissue. Some organs were more affected than others and showed the possibility that each

tissue depends on PER2 to a different degree. For example, the SCN (which is the brain's master

clock) holds onto its rhythms more than other organs. This might be because the SCN has extra

mechanisms or stronger cell-to-cell connections that help it stay on track even without PER2.

This kind of variation was also seen in the Hoshi et al. study where PER2 loss had big effects on

gene timing in the skin, but not all the genes were affected. Some stayed rhythmic while others

did not. This shows that PER2 only controls specific genes depending on the tissue, meaning that

future treatments or gene edits that involve PER2 would need to be very carefully targeted.

Otherwise, accidental disruptions may take place in the important pathways in organs that don't

need to be affected.

Off Target Effects

In addition to its role in keeping our body clock on track, Grimaldi and colleagues (2011) found

that PER2 also plays a big part in metabolism, especially in how the body handles fat. They

discovered that PER2 binds to a gene called PPARγ which is crucial for the development of fat

cells. Under normal conditions, PER2 helps keep this gene under control. But when PER2 is

removed, that control is lost and leads to lower body fat, fewer triglycerides, and free fatty acids,

and even changes in how the body responds to insulin. This means PER2 isn't just about sleep

and circadian rhythms. Rather, it also plays a part in how the body stores and uses energy. That's

why changing PER2, even if it's just to study the internal clock, could unintentionally trigger

serious metabolic effects. This is a big deal for researchers using tools like CRISPR or siRNA

and changing PER2 might impact fat metabolism, blood sugar, or liver function, even if that

wasn't the goal.

The research reviewed here makes it clear that PER2 is greatly involved in many different

processes in the body. It's not just a timekeeper for circadian rhythms, but rather also helps

control when and where certain proteins and genes are active, and play a role in metabolism.

Qian et al.'s data showed how losing PER2 results in major disruptions in protein rhythms across

many tissues; Hoshi et al. showed that some genes depend on PER2 in specific tissues, like skin;

Grimaldi et al. showed that PER2 deletion messes with fat storage and insulin sensitivity. As

researchers look into using PER2 as a target for circadian-based treatments, they will need to be

careful. Changing PER2 could affect far more than just the human clock, especially if the

changes are not limited to the right time and place. Any gene editing or drug that targets PER2

needs to be designed carefully, because messing with it could lead to unexpected side effects in

metabolism, as well as wound healing and other important body functions.

Ethical and Safety Concerns

Gene editing tools like CRISPR offer favorable ways to treat disorders tied to our internal clocks

by targeting key genes like PER2. But because PER2 affects not just sleep, but also brain

function, mood, and metabolism, editing it raises serious ethical and safety concerns. While it's

crucial in keeping our 24-hour rhythms running smoothly, it also impacts emotional balance and

how our bodies use energy. That means changing PER2 is a technical hurdle, and it also brings

up questions about long-term safety, unintended effects, and where we draw the line between

treating illness and enhancing human abilities.

Editing the Brain and Behavior

Since PER2 is expressed in the suprachiasmatic nucleus of the brain and influences sleep-wake

cycles, editing it would involve altering brain function. According to Cohen et al. (2020),

modifying genes that affect behavior raises concerns about identity, autonomy, and personal

well-being. If gene editing was used not just to treat disorders, but also to increase productivity

or reduce sleep needs, it could be brought into enhancement where individuals could look to

optimize performance rather than restore health. This creates a slippery type situation where the

original goal of treating sleep disorders blurs into optional enhancement. In competitive

environments, this could lead to pressure on individuals to undergo gene editing to keep up and

result in raising fairness and ethical access concerns.

Long-Term Consequences and Gene-Environment Interactions

Editing PER2 could also have unpredictable long-term consequences, both biologically and

socially. As Mulvihill et al. (2017) explain, genetic interventions do not act alone as they interact

with an individual's environment, lifestyle, and health conditions. PER2 is involved in more than

sleep since it's linked to metabolism, hormone release, and mood regulation – changing it may

affect far more than intended. There's also the issue of off-target effects, where edits affect

unintended parts of the genome. These errors may not be immediately visible but could cause

problems years later. Since the circadian system affects so many parts of the body, even small

changes can have wide-reaching effects. That's why long-term monitoring and follow-up are so

important, especially in clinical trials, to catch any unexpected issues that might show up over

time.

Informed Consent in Clinical Settings

A major ethical concern when targeting PER2 in clinical trials is informed consent. Since the

effects of editing PER2 may take years to fully appear, participants may not understand what

they're agreeing to. De Araujo (2020) argues that ethical trials must go beyond short-term risks

and explain the unknowns, which include but are not limited to emotional, behavioral, and social

outcomes. This is important when editing genes that affect the brain. Even small changes in

mood or alertness might not be noticeable at first, but they can still have a big impact on a

person's quality of life. That's why informed consent needs to reflect this complexity and make

sure patients clearly understand both the potential benefits and the possible risks.

Potential for Enhancement Misuse

One of the most difficult challenges is preventing the misuse of PER2 editing for non-medical

enhancement. If gene therapy can reduce sleep needs or improve mental focus, it may be

marketed for performance enhancement rather than therapy. As Cohen et al. (2020) warn, this

could deepen inequalities if only certain groups can access any of the enhancement technologies.

It also raises more ethical questions such as “Should we edit human traits like sleep or

wakefulness for personal gain?” And if so, who will decide if that is acceptable? These questions

are beyond biology and step into the realm of social values, policy, and fairness.

Gene editing that targets PER2 shows real promise for treating circadian rhythm disorders,

especially when traditional treatments are not effective. However, because PER2 affects many

systems in the body, particularly the brain, it creates serious ethical and safety concerns. These

include the potential for misuse as an enhancement, unintended genetic changes, and challenges

with ensuring fully informed consent. As gene editing therapies continue to develop, especially

in areas related to sleep and brain function, the scientific community must proceed with caution

and prioritize safety, fairness, and clear communication with patients.

Future Directions and Potential

The Promise of Personalized Gene Therapies

Gene therapy targeting PER2 offers the possibility of more personalized treatments for circadian

rhythm disorders. It can influence not only sleep but also mood and metabolic health. As

Roenneberg and Merrow (2016) explain, each person has a unique biological clock, known as a

chronotype, that is partly shaped by genetics. This helps explain why some people are naturally

early risers while others tend to stay up late. Problems occur when these internal clocks become

out of sync with the environment or daily responsibilities. Researchers could develop gene

therapies that are made to their specific sleep patterns and genetic makeup by understanding

individual circadian biology and making the treatments more effective than the standard

approach.

Safer and Precise Gene Delivery Systems

For gene therapy to be successful, especially when working with something as delicate as the

brain, it's crucial to have safe and reliable delivery methods. Traditional CRISPR techniques

work by cutting both strands of DNA, which can lead to problems like unintended mutations or

even permanent damage. To reduce these risks, scientists are exploring newer approaches to gene

editing. One promising method that was introduced by Anzalone and colleagues in 2019, is

called prime editing. This helps researchers find and replace specific DNA sequences without

cutting both strands or needing a separate DNA template. As a result, the editing process is more

precise and less likely to cause harmful side effects. This is important when targeting a gene like

PER2 since it helps regulate essential biological rhythms.

Reversible/Non Permanent Gene Modulation

Another exciting area of development is the use of reversible or non-permanent editing

techniques. Instead of altering DNA directly, researchers can control the gene activity at the

epigenetic level. Liao et al. (2017) performed a method of gene activation using CRISPR

systems while fusing it with epigenetic modifiers which are essentially turning genes on or off

without making lasting changes to the genetic code. This “trans epigenetic” approach could be

helpful for regulating genes like PER2, where flexible or temporary changes might be safer than

permanent ones. For instance, if someone needs to adjust their sleep-wake cycle, the activity of

the gene could increase or decrease as needed without causing lasting changes to their DNA.

Conclusion

The PER2 gene plays an important role when it comes to managing our internal body clock,

which affects certain processes like when we feel tired, when we wake up, and how our body

stays in sync throughout the day. When something goes wrong with PER2, it can throw off our

circadian rhythm and result in problems like sleep issues like Delayed Sleep Phase Syndrome

where individuals will struggle to fall asleep or wake up at normal times.

Gene editing tools like CRISPR have opened up the possibility of fixing these kinds of problems

at the genetic level. Being able to directly adjust the genes that control our sleep and wake-up

cycle is an exciting idea and could lead to more effective treatments. But at the same time, there

are also a lot of challenges that are present. It is not that easy to make changes to a gene like

PER2 since it follows a strict daily rhythm and is only active in certain parts of the brain. There

is also the risk of editing the wrong genes, which may cause unwanted side effects, and also

ethical concerns that persist among many, counterarguing against gene editing as a whole.

Looking ahead, future research on PER2 should focus on understanding its behavior in more

detail. This includes how it interacts with other clock genes and environmental factors like light

and temperature, seeing as the circadian rhythm is highly responsive to external conditions.

Since PER2 follows a specific rhythm on a daily basis, it is essential that researchers study when

and where this gene is active in the body, especially in the brain's suprachiasmatic nucleus. By

tracking the activities of PER2 more clearly, scientists can determine how to time gene editing

treatments in a better way so that they can support the body's natural state rather than disrupt it.

Another important area of research is improving gene editing's safety and capability to be used

on a widespread scale. Technologies like CRISPR-Cas9, CRISPRa/i, and base editors show

promise but also come with risks, such as off-target edits and unintended changes in gene

expression even with. Future studies should aim to develop more precise versions of these tools

that can target PER2 in the SCN without affecting other parts of the brain or body. Researchers

should also explore reversible or non-permanent gene editing techniques, like CRISPR

interference (CRISPRi), to lower the risk of long-term side effects.

Additionally, more research that is focused on humans is needed. While animal models have

allowed us to discover a lot about PER2, human circadian rhythms are more complex and

influenced by lifestyle, social factors, and individual genetics. Future clinical trials should also

take these differences into account and include diverse populations. It will also be crucial to

design ethical studies that focus on informed consent, especially since gene editing in the brain

could impact unrelated, external qualities such as behavior, mood, and other quality-of-life

standards.

Overall, gene editing has the potential to become an influential tool for treating sleep disorders in

the future, but we're not at that stage yet. More research needs to be done to make sure these

treatments are safe and used responsibly. Learning more about PER2 will help us move in the

right direction and provide us with a better understanding of how we might treat these disorders

down the line.

References

Abudayyeh, O. O., & Gootenberg, J. S. (2021). CRISPR applications in living cells. Science,

372(6537), 271–275. https://doi.org/10.1126/science.abe6132

Anzalone, A. V., et al. (2019). Search-and-replace genome editing without double-strand breaks

or donor DNA. Nature, 576(7785), 149–157. https://doi.org/10.1038/s41586-019-1711-4

Bass, J., & Takahashi, J. S. (2010). Circadian integration of metabolism and energetics. Science,

330(6009), 1349–1354. https://doi.org/10.1126/science.1195027

Brenna, A., & Albrecht, U. (2020). Phosphorylation and Circadian Molecular Timing. Frontiers

in Physiology, 11. https://doi.org/10.3389/fphys.2020.612510

Choi, H., et al. (2021). PER2 modulates dopaminergic function and reward-related behavior. Cell

Reports, 36(2), 109403. https://doi.org/10.1016/j.celrep.2021.109403

Cohen, I. G., et al. (2020). The ethics of human enhancement: Understanding the debate.

Hastings Center Report, 50(S1), S2–S11. https://doi.org/10.1002/hast.1090

de Araujo, M. (2020). The ethics of genetic cognitive enhancement: Gene editing or embryo

selection? Philosophies, 5(2), 8. https://doi.org/10.3390/philosophies5020008

Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with

CRISPR-Cas9. Science, 346(6213), 1258096. https://doi.org/10.1126/science.1258096

Dyar, K. A., et al. (2014). Transcriptional programming of lipid and amino acid metabolism by

the skeletal muscle circadian clock. PLoS Biology, 12(11), e1001958.

https://doi.org/10.1371/journal.pbio.1001958

Etchegaray, J. P., et al. (2009). The Polycomb group protein EZH2 is required for mammalian

circadian clock function. The Journal of Biological Chemistry, 284(9), 6459–6464.

https://doi.org/10.1074/jbc.M808020200

Fu, W., et al. (2022). PER2: A regulator of the circadian clock and cancer. Frontiers in Oncology,

12, 872261. https://doi.org/10.3389/fonc.2022.872261

Fu, L., et al. (2002). The circadian gene Period2 plays an important role in tumor suppression

and DNA damage response in vivo. Cell, 111(1), 41–50.

https://doi.org/10.1016/S0092-8674(02)00961-3

Grimaldi, B., et al. (2011). PER2 controls lipid metabolism by direct regulation of PPARγ. Cell

Metabolism, 14(4), 491–503. https://doi.org/10.1016/j.cmet.2011.07.016

Hampp, G., et al. (2008). Regulation of monoamine oxidase A by the circadian clock protein

Per2. Proceedings of the National Academy of Sciences, 105(19), 6560–6565.

https://doi.org/10.1073/pnas.0708692105

Hildebrand, M. S., et al. (2021). Circadian regulation of hearing and balance. F1000Research,

10, F1000 Faculty Rev-347. https://doi.org/10.12688/f1000research.52530.1

Hirano, A., et al. (2016). Chemical control of circadian behavior in mice by selective inhibition

of casein kinase 1δ/ε. Proceedings of the National Academy of Sciences, 113(25),

7011–7016. https://doi.org/10.1073/pnas.1601893113

Hirao, A., et al. (2010). Widespread tissue circadian clocks in mice revealed by

mPER2::luciferase bioluminescence imaging. Proceedings of the National Academy of

Sciences, 107(8), 3072–3077. https://doi.org/10.1073/pnas.0913187107

Hoshi, T., et al. (2017). Circadian rhythms of angiogenic factors in skin and wound tissue in

Per2-mutant mice. Biomedical Research and Clinical Practice, 2(3).

https://www.oatext.com/pdf/BRCP-2-135.pdf

Jacobi, D., et al. (2015). Oxidative stress and circadian clock disruption promote

neurodegeneration. Frontiers in Aging Neuroscience, 7, 30.

https://doi.org/10.3389/fnagi.2015.00030

Jinek, M., et al. (2012). A programmable dual–RNA–guided DNA endonuclease in adaptive

bacterial immunity. Science, 337(6096), 816–821.

https://doi.org/10.1126/science.1225829

Jing, Y., et al. (2021). Circadian Gene PER2 Silencing Downregulates PPARG and SREBF1 and

Suppresses Lipid Synthesis in Bovine Mammary Epithelial Cells. Biology, 10(12),

1226–1226. https://doi.org/10.3390/biology10121226

Khan, I., et al. (2018). Advances in viral vector-based gene delivery for gene therapy. Current

Drug Delivery, 15(2), 164–176. https://doi.org/10.2174/1567201814666170223142502

Komor, A. C., et al. (2016). Programmable editing of a target base in genomic DNA without

double-stranded DNA cleavage. Nature, 533(7603), 420–424.

https://doi.org/10.1038/nature17946

Kovanen, L., et al. (2021). Transcriptomic analysis reveals circadian disruption in human

delayed sleep phase disorder. Scientific Reports, 11(1), 22465.

https://doi.org/10.1038/s41598-021-01523-x

Lee, H.-J., et al. (2011). Posttranslational regulation of circadian rhythm: Ubiquitination of PER2

by β-TrCP1 and its relevance to the FASPS mutation. Cell Cycle, 10(5), 719–726.

https://doi.org/10.4161/cc.10.5.14974

Lee, C., et al. (2006). Posttranslational mechanisms regulate the mammalian circadian clock.

Cell, 125(6), 1013–1024. https://doi.org/10.1016/j.cell.2006.03.039

Liao, H. K., et al. (2017). In vivo target gene activation via CRISPR/Cas9-mediated

trans-epigenetic modulation. Cell, 171(7), 1495–1507.e15.

https://doi.org/10.1016/j.cell.2017.10.025

Masuda, T., et al. (2020). The molecular basis of PER2 protein stability and its modulation by

phosphorylation. Cell Reports, 30(13), 4295–4307.e5.

https://doi.org/10.1016/j.celrep.2020.03.035

Miyake, N., et al. (2023). Temperature-dependent regulation of PER2 translation via uORF

suppression. iScience, 26(2), 106041. https://doi.org/10.1016/j.isci.2023.106041

Mulvihill, J. J., et al. (2017). Ethical issues of CRISPR technology and gene editing through the

lens of solidarity. British Medical Bulletin, 122(1), 17–29.

https://doi.org/10.1093/bmb/ldx002

Narasimamurthy, R., & Virshup, D. M. (2018). PER2 protein stability and circadian period

determination. Frontiers in Physiology, 9, 1064.

https://doi.org/10.3389/fphys.2018.01064

Nguyen, K. V., et al. (2013). Circadian gene PER2 inhibits mTORC1 signaling and regulates

lipid metabolism. Cell Reports, 5(6), 1611–1621.

https://doi.org/10.1016/j.celrep.2013.11.028

Patke, A., et al. (2017). Mutation of the human circadian clock gene CRY1 in familial delayed

sleep phase disorder. Cell, 169(2), 203–215.e13.

https://doi.org/10.1016/j.cell.2017.03.027

Qi, L. S., et al. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific

control of gene expression. Cell, 152(5), 1173–1183.

https://doi.org/10.1016/j.cell.2013.02.022

Qian, J., et al. (2023). A multi-tissue proteomics atlas of wild-type and Per1/Per2 knockout mice.

Molecular & Cellular Proteomics, 22(7), 100539.

https://doi.org/10.1016/j.mcpro.2023.100539

Roenneberg, T., & Merrow, M. (2016). The circadian clock and human health. Current Biology,

26(10), R432–R443. https://doi.org/10.1016/j.cub.2016.04.011

Sancar, A., et al. (2015). Circadian clock control of the cellular response to DNA damage. FEBS

Letters, 589(14), 1636–1644. https://doi.org/10.1016/j.febslet.2015.05.015

Smith, R. T., et al. (2018). Circadian rhythms and delayed sleep phase disorder: Current

perspectives. Nature and Science of Sleep, 10, 1–9. https://doi.org/10.2147/NSS.S124503

Takumi, T., et al. (2015). Molecular architecture of the circadian clock in the mammalian

suprachiasmatic nucleus. Frontiers in Neuroscience, 9, 101.

https://doi.org/10.3389/fnins.2015.00101

Toh, K. W., et al. (2001). A hPer2 phosphorylation site mutation in familial advanced sleep phase

syndrome. Science, 291(5506), 1040–1043. https://doi.org/10.1126/science.1057499

Vanselow, K., et al. (2024). Temperature compensation of circadian rhythms is controlled by the

stability of PERIOD proteins. Nature Communications, 15, 1056.

https://doi.org/10.1038/s41467-024-44653-2

Virshup, D. M., Eide, E. J., Forger, D. B., Gallego, M., & Harnish, E. V. (2007). Reversible

Protein Phosphorylation Regulates Circadian Rhythms. Cold Spring Harbor Symposia on

Quantitative Biology, 72, 413–420. https://doi.org/10.1101/sqb.2007.72.048

Wheaton, A. G., et al. (2016). Prevalence of healthy sleep duration among adults — United

States, 2014. Morbidity and Mortality Weekly Report, 65(6), 137–141.

https://doi.org/10.15585/mmwr.mm6506a1

Xu, Y., et al. (2005). Functional consequences of a CKIδ mutation causing familial advanced

sleep phase syndrome. Nature, 434(7033), 640–644. https://doi.org/10.1038/nature03453

Zetsche, B., et al. (2015). A split-Cas9 architecture for inducible genome editing and

transcription modulation. Nature Biotechnology, 33(2), 139–142.

https://doi.org/10.1038/nbt.3149

Zhang, H., et al. (2021). Application of the CRISPR/Cas9-based Gene Editing Technique in

Basic research, diagnosis, and Therapy of Cancer. Molecular Cancer, 20(1), 126.

https://doi.org/10.1186/s12943-021-01431-6

Zhang, R., et al. (2017). Liver clock regulates the diurnal rhythm of glucocorticoid signaling

through HDAC3. Cell Metabolism, 25(4), 707–718.

https://doi.org/10.1016/j.cmet.2017.01.006

Zhang, Y., et al. (2016). Disruption of the PER2 gene induces obesity in mice. Frontiers in

Physiology, 7, 592. https://doi.org/10.3389/fphys.2016.00592

Zheng, B., et al. (1999). The mPer2 gene encodes a functional component of the mammalian

circadian clock. Nature, 400(6740), 169–173. https://doi.org/10.1038/22118